Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

Caribou Biosciences, Inc. · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
car-t-cellscell-therapymultiple-myeloma
relapsed/refractory multiple myeloma, cammouflage, allogeneic, multiple myeloma, relapse refractory multiple myeloma, car-t cells, bcma, cell therapy, cellular immuno-therapy, cb11a, cb-011, cb-011a
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 876910
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.